14642942

Chiesa-Montadou S

2003

[About two complications of ovarian drilling by fertiloscopy].

14644023

Wei AY

2003

Therapy for polycystic ovarian syndrome.

14644808

Strauss JF 3rd

2003

Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.

14644809

Driscoll DA

2003

Polycystic ovary syndrome in adolescence.

14644812

Spiliotis BE

2003

Growth hormone insufficiency and its impact on ovarian function.

14644838

Bruni V

2003

The management of polycystic ovary syndrome.

14644839

Diamanti-Kandarakis E

2003

Conservative management of gynecologic diseases: insulin sensitizing agents in polycystic ovary syndrome.

14645162

van Santbrink EJ

2003

Is there a future for ovulation induction in the current era of assisted reproduction?

14645192

Maliqueo M

2003

Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction?

14648180

Parsanezhad ME

2004

A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.

14653891

Kolibianakis E

2003

Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI.

14655805

Stulberg DL

2003

Common hyperpigmentation disorders in adults: Part II. Melanoma, seborrheic keratoses, acanthosis nigricans, melasma, diabetic dermopathy, tinea versicolor, and postinflammatory hyperpigmentation.

14656055

Forneris ML

2003

A neuroimmune regulation at peripheral level on the steroidogenesis of polycystic ovary in rats.

14661444

Toldy E

2003

[Macroprolactinemia in the differential diagnosis of hyperprolactinemia].

14664406

Panidis DK

2003

Could the theory of chaos contribute to the interpretation of pathogenesis of polycystic ovary syndrome?

14664414

Panidis D

2003

Serum leptin levels in normal-weight and overweight women with polycystic ovary syndrome.

14664878

Calaf Alsina J

2003

Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.

14665448

Ehrmann DA

2004

Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome.

14665701

Oksjoki S

2004

Differences in connective tissue gene expression between normally functioning, polycystic and post-menopausal ovaries.

14666761

Hua L

2003

[Clinical study of yishen jianpi yangxue tongli therapy in treating polycystic ovary syndrome].

14667885

Moran C

2003

Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome.

14669168

Glueck CJ

2003

Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss.

14670212

Keegan A

2003

'Hirsutism': a psychological analysis.

14671144

Coffler MS

2003

Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone.

14671172

Elsenbruch S

2003

Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.

14671186

Orio F Jr

2003

Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome.

14671189

Tsilchorozidou T

2003

Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.

14671196

Pigny P

2003

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

14671199

Xita N

2003

Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels.

14671415

Bai YH

2004

Electro-acupuncture reverses nerve growth factor abundance in experimental polycystic ovaries in the rat.

14676484

Amin M

2003

Minireview: Up-date management of non responder to clomiphene citrate in polycystic ovary syndrome.

14677661

Nothnagle M

2003

Does metformin improve clinical features of polycystic ovary syndrome?

14678281

Tsilchorozidou T

2004

The pathophysiology of polycystic ovary syndrome.

14678290

Patel K

2004

Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.

14678951

van Dam EW

2004

Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.

14680609

Zhao JZ

2003

[Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].

14680786

Reyss AC

2003

[Revelation of a polymicrocystic ovary syndrome after one month's treatment by pulsatile GnRH in a patient presenting with functional hypothalamic amenorrhea].

14684846

Wickenheisser JK

2004

Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.

14687063

Fielding AM

2004

Serum LH analysis: solutions and problems.

14688154

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.

2004

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

14688155

Seow KM

2004

Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance.

14688186

Orio F Jr

2004

Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome?

14688189

Lass A

2004

Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome.

14698982

Gottschalk ME

2003

Adolescents, polycystic ovary syndrome, and insulin resistance syndrome.

14698983

Nestler JE

2003

Insulin resistance syndrome and polycystic ovary syndrome.

14699481

Lederman ER

2004

Image of the month.

14704263

Guzick DS

2004

Polycystic ovary syndrome.

14704875

Erbas T

2003

Metabolic syndrome.

14709856

Kamel N

2003

The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.

14710585

Coffey S

2003

The effect of polycystic ovary syndrome on health-related quality of life.

14710586

Cenk Sayin N

2003

Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome.

14711538

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.

2004

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

14711552

Comim FV

2004

Increased growth hormone response to clonidine in nonobese normoinsulinemic patients with polycystic ovary syndrome.

14711553

Genazzani AD

2004

Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.

14711554

Farah-Eways L

2004

Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.

14711555

Moran C

2004

Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.

14711571

Yarali H

2004

A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively.

14714587

Balen AH

2003

Ultrasound assessment of the polycystic ovary: international consensus definitions.

14715840

Skrha J

2004

Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders.

14715857

Baillargeon JP

2004

Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.

14715867

Laven JS

2004

Anti-M?llerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

14717558

Bacon WL

2003

Influence of photoperiod and age of photostimulation on the incidence of polycystic ovarian follicle syndrome in turkey breeder hens.

14719312

Calvar CE

2003

[Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance].

14722511

Cedars MI

2004

Polycystic ovary syndrome: what is it and how should we treat it?

14722514

Ib??ez L

2004

Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.

14722518

Gungor N

2004

Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents.

14725687

Gambineri A

2004

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

14728846

Ye BL

2003

[Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].

14728858

Zhu WJ

2003

[Transvaginal follicular aspiration in follicle phase in the management of anovulation associated with polycystic ovary syndrome].

14736594

Trim?che S

2004

[Polycystic ovary syndrome in pubertal period: clinical, biological, metabolic and genetic polymorphism].

14736706

McCartney CR

2004

Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome.

14737959

Banaszewska B

2003

Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.

14739186

Bayram N

2004

Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial.

14740344

Schr?der AK

2003

[Insulin resistance in polycystic ovary syndrome].

14740540

Radulovi? A

2003

[Obesity and hormone function changes in female patients with polycystic ovaries].

14744836

Tatum WO 4th

2004

Updates on the treatment of epilepsy in women.

14747184

Jones GL

2004

The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation.

14747186

van Hooff MH

2004

Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years.

14748678

Norman RJ

2004

4: Polycystic ovary syndrome.

14748954

Geisth?vel F

2003

A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome.

14749349

Rodr?guez S

2004

Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits.

14752300

McCarthy EA

2004

Metformin in obstetric and gynecologic practice: a review.

14752302

Legro RS

2004

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

14752604

Dicker A

2004

Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots.

14755361

Tauchert S

2003

[The use of oral antidiabetic drugs in the treatment of polycystic ovary syndrome].

14755945

Teleman S

2003

[Morphological correlations between endometrial hyperplasias, uterine leiomyoma and ovarian associated lesions].

14758568

St?rka L

2004

Hormonal profile of men with premature balding.

14760714

Cort?n M

2004

Improved resolution of the human adipose tissue proteome at alkaline and wide range pH by the addition of hydroxyethyl disulfide.

14763920

Vrb?kov? J

2004

Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.

14764283

Seli E

2004

Treatment of PCOS with metformin and other insulin-sensitizing agents.

14764747

Azziz R

2004

Androgen excess in women: experience with over 1000 consecutive patients.

14764771

Kasim-Karakas SE

2004

Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome.

14764797

Carbunaru G

2004

The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.

14764799

Escobar-Morreale HF

2004

Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.

14764802

Jakubowicz DJ

2004

Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy.

14764814

Cousin P

2004

Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women.

14770401

Phy J

2004

Transvaginal ultrasound detection of multifollicular ovaries in non-hirsute ovulatory women.

14804674

McCUTCHEN GT

1951

Bilateral polycystic ovaries (large white ovaries).

14837995

LEVENTHAL ML

1951

Bilateral polycystic ovaries, the Stein syndrome.

14838382

VARA P

1951

The Stein-Leventhal syndrome.